Vorinostat (SAHA) in Uterine Sarcoma

Stopped The early termination was NOT due to safety reasons, terminated because of the very slow recruitment and problematic access to the study medication in Europe

Conditions

• Leiomyosarcoma
• Endometrial Stromal Tumors
• Carcinosarcomas Uterine

Interventions

• DRUG: Vorinostat Oral Capsule

Sponsor

Medical University of Graz